Sign in
4/A

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001209191-20-060791

Chief Medical Officer sold 17,500 shares at an average $18.45 ($322,834)

  • Chief Medical Officer acquired 17,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2018-12-03 Option exercise +17,500 $5.28 $92,400 195,625 I
Ho Carole Chief Medical Officer 2018-12-03 Sale −17,100 $18.43 $315,170 178,525 I
Ho Carole Chief Medical Officer 2018-12-03 Sale −400 $19.16 $7,664 178,125 I
Derivatives
Ho Carole Chief Medical Officer 2018-12-03 Option exercise · Stock Option (right to buy) +17,500 84,375 D
Open-market sales · 17,500 sh · avg $18.45 · $322,834
Loading xslF345X03/doc4a.xml…